logo
Select company
Select metric
$ -0.21Operating Cash Flow per Share
VS
Market
27
Sector
65
Industry
86
History
73
$ 2.02Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information

Ticker

MREO

Company Name

MEREO BIOPHARMA GROUP PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEREO BIOPHARMA GROUP PLC - Operating Cash Flow per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MREO - OCFPS Historical data
DateNet Cash Flow - OperationsOperating Cash Flow per ShareShare FactorWeighted Average Shares
6/30/2025$ -32.92M$ -0.210.2799.44M
3/31/2025$ -33.17M$ -0.210.2784.28M
12/31/2024$ -32.83M$ -0.220.2739.62M
9/30/2024$ 0$ 00.2770.15M
6/30/2024$ -20.45M$ -0.140.2711.77M
3/31/2024$ 0$ 00.2700.26M
12/31/2023$ -21.13M$ -0.160.2659.45M
6/30/2023$ -41.59M$ -0.320.2643.2M
12/31/2022$ -48.52M$ -0.390.2624.93M
6/30/2022$ -42.43M$ -0.360.2584.91M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) OCFPS stands at $ -0.52.
  • Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average OCFPS has been $ -0.24.
  • The median OCFPS for MEREO BIOPHARMA GROUP PLC during this period was $ -0.21
  • MEREO BIOPHARMA GROUP PLC reached its highest OCFPS over the past 5 years at $ -0.06.
  • The lowest OCFPS recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe $ -0.52

MEREO BIOPHARMA GROUP PLC's OCFPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCFPS Benchmarks
CompanyOCFPS
CRDF : CARDIFF ONCOLOGY INC $ -0.63ABEO : ABEONA THERAPEUTICS INC $ -1.26HUMA : HUMACYTE INC $ -0.67AVTX : AVALO THERAPEUTICS INC $ -4.38COYA : COYA THERAPEUTICS INC $ -0.98ABVC : ABVC BIOPHARMA INC $ -0.1FDMT : 4D MOLECULAR THERAPEUTICS INC $ -2.98VTGN : VISTAGEN THERAPEUTICS INC $ -1.57ERNA : ERNEXA THERAPEUTICS INC $ -2.79ANNX : ANNEXON INC $ -1.05

Similar metrics to Shares WA:

Definition of Operating Cash Flow per Share

[Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS OCFPS for MEREO BIOPHARMA GROUP PLC is calculated as follows: CF - Operations [ $ -35.43M ] / (Shares WA [ 338.95M ] * Share Factor [ 0.2 ])
(=) OCFPS [ $ -0.52 ]

MREO - Operating Cash Flow per Share, Last 5 years

$ -0.52

Minimum

Dec 31, 2020

$ -0.06

Maximum

Dec 31, 2021

$ -0.24

Average

$ -0.21

Median

OCFPS Benchmark Analysis

 The chart above depicts the distribution of OCFPS for companies in the Total Stock Market. The average OCFPS of the companies is $ 1.65 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
OCFPS in the Market:
filtered constituents3.79K
min$ -9.04
max$ 11.43
average$ 1.65
median$ 0.89
std$ 3.42